1,450
Views
11
CrossRef citations to date
0
Altmetric
Research Paper

Orosomucoid 1 promotes epirubicin resistance in breast cancer by upregulating the expression of matrix metalloproteinases 2 and 9

ORCID Icon &
Pages 8822-8832 | Received 16 Aug 2021, Accepted 24 Sep 2021, Published online: 27 Oct 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Weixin Zhang, Qi Liu, He Zhu, Chao Ma, Qin Luo, Meilin Ji & Li Liu. (2022) Propofol induces the apoptosis of neural stem cells via microRNA-9-5p / chemokine CXC receptor 4 signaling pathway. Bioengineered 13:1, pages 1062-1072.
Read now
Yi Chen, Weiwei Tang, Xuedan Zhu, Lele Zhang, Yinxing Zhu, Hua Xiao, Jin Xu, Yueyu Fang, Xiao Li, Cuiju Tang & Junfeng Shi. (2021) Nuclear receptor binding SET domain protein 1 promotes epithelial-mesenchymal transition in paclitaxel-resistant breast cancer cells via regulating nuclear factor kappa B and F-box and leucine-rich repeat protein 11. Bioengineered 12:2, pages 11506-11519.
Read now

Articles from other publishers (9)

Yunwei Zhang, Yunping Guan, Xinyu Zheng & Chenyang Li. (2024) Hypoxia-induced miR-181a-5p up-regulation reduces epirubicin sensitivity in breast cancer cells through inhibiting EPDR1/TRPC1 to activate PI3K/AKT signaling pathway. BMC Cancer 24:1.
Crossref
Yuxiang Bao, Zhongliang Yan, Nianmei Shi, Xiaoyan Tian, Jiayang Li, Taolang Li, Xiaoming Cheng & Junyuan Lv. (2024) LCN2: Versatile players in breast cancer. Biomedicine & Pharmacotherapy 171, pages 116091.
Crossref
Gang Yu, Juan Gao, Weifeng Hu, Dayong Hu, Weibing Wang, Shiquan Yang & Jing Gao. (2023) ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through CALR-mediated apoptosis. Scientific Reports 13:1.
Crossref
Lei Yue, Xiaozhang Xu, Shipeng Dai, Fan Xu, Wenhu Zhao, Jian Gu, Xinzheng Dai & Xiaofeng Qian. (2023) Orosomucoid 1 promotes colorectal cancer progression and liver metastasis by affecting PI3K/AKT pathway and inducing macrophage M2 polarization. Scientific Reports 13:1.
Crossref
Sung Hye Kong, Joon-Hyop Lee, Jeong Mo Bae, Namki Hong, Hyeyoon Kim, So Young Park, Yong Jun Choi, Sihoon Lee, Yumie Rhee, Sang Wan Kim, Dohyun Han, Jung Hee Kim & Chan Soo Shin. (2023) In-depth proteomic signature of parathyroid carcinoma. European Journal of Endocrinology 188:4, pages 385-394.
Crossref
Dzohara Murillo, Carmen Huergo, Borja Gallego, René Rodríguez & Juan Tornín. (2023) Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer. Biomedicines 11:1, pages 208.
Crossref
Jiaoxia He, Zhongling Zheng, Tingting Liu, Yupei Ao, Yixuan Yang & Huaidong Hu. (2022) Salivary orosomucoid 1 as a biomarker of hepatitis B associated hepatocellular carcinoma. Scientific Reports 12:1.
Crossref
Bernadette Xin Jie Tune, Maw Shin Sim, Chit Laa Poh, Rhanye Mac Guad, Choy Ker Woon, Iswar Hazarika, Anju Das, Subash C. B. Gopinath, Mariappan Rajan, Mahendran Sekar, Vetriselvan Subramaniyan, Neeraj Kumar Fuloria, Shivkanya Fuloria, Kalaivani Batumalaie & Yuan Seng Wu. (2022) Matrix Metalloproteinases in Chemoresistance: Regulatory Roles, Molecular Interactions, and Potential Inhibitors. Journal of Oncology 2022, pages 1-25.
Crossref
Shrey S Sukhadia, Aayush Tyagi, Vivek Venkataraman, Pritam Mukherjee, Pratosh Prasad, Olivier Gevaert & Shivashankar H Nagaraj. (2022) ImaGene: a web-based software platform for tumor radiogenomic evaluation and reporting. Bioinformatics Advances 2:1.
Crossref